Medicare Enrolled

Dr. Susanne Lockhart, MD

Dermatology · Prosper, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1030 S COIT RD, Prosper, TX 75078
4697693376
In practice since 2006 (19 years)
NPI: 1497857585 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lockhart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lockhart? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lockhart

Dr. Susanne Lockhart is a dermatology specialist in Prosper, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lockhart performed 2,061 Medicare services across 1,036 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lockhart received a total of $12,771 from 48 pharmaceutical and/or device companies across 465 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lockhart is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 2,061 Medicare services $12,771 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,061
Medicare services
Bottom 48% in TX for dermatology
1,036
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~108 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 916 $5 $13
Office visit, established patient (30-39 min) 377 $77 $249
Destruction of precancerous skin growth, 1 238 $34 $131
Destruction of skin growths (warts/lesions), 1-14 157 $75 $221
Skin biopsy, tangential 115 $58 $198
New patient office visit (45-59 min) 71 $97 $323
Office visit, established patient (20-29 min) 68 $57 $176
Biopsy of related skin growth, each additional growth 30 $36 $98
Office visit, established patient (10-19 min) 22 $30 $111
New patient office visit (30-44 min) 20 $65 $217
Destruction of precancer skin growth, 15 or more growths 19 $114 $328
Injection into skin growth, 1-7 growths 15 $32 $111
Steroid injection (triamcinolone) 13 $1 $2
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,771
Total received (2018-2024)
Avg $1,824/year across 7 years
Top 20% in TX for dermatology
48
Companies
465
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,771 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,569
2023
$1,545
2022
$1,062
2021
$941
2020
$1,385
2019
$2,580
2018
$2,689

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Ortho Dermatologics, a division of Bausch Health US, LLC
$2,631
ABBVIE INC.
$1,102
Novartis Pharmaceuticals Corporation
$987
Regeneron Healthcare Solutions, Inc.
$953
Janssen Biotech, Inc.
$877
Sun Pharmaceutical Industries Inc.
$702
Amgen Inc.
$545
LEO Pharma Inc.
$527
Galderma Laboratories, L.P.
$409
PFIZER INC.
$369
Encore Dermatology Inc.
$358
AbbVie Inc.
$357
SUN PHARMACEUTICAL INDUSTRIES INC.
$286
GENZYME CORPORATION
$235
AbbVie, Inc.
$213
UCB, Inc.
$210
E.R. Squibb & Sons, L.L.C.
$190
Journey Medical Corporation
$173
VYNE Pharmaceuticals Inc.
$172
Almirall LLC
$158
DERMIRA, INC.
$134
Allergan, Inc.
$131
Mayne Pharma Inc.
$131
Celgene Corporation
$117
Lilly USA, LLC
$114
EPI Health, LLC
$93
Incyte Corporation
$85
PruGen, Inc. Pharmaceuticals
$67
Taro Pharmaceuticals USA, Inc.
$65
Glenmark Therapeutics Inc.
$33
MAYNE PHARMA INC.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Genentech USA, Inc.
$30
Mission Pharmacal Company
$26
Verrica Pharmaceuticals Inc.
$24
Aclaris Therapeutics, Inc.
$22
Arcutis Biotherapeutics, Inc.
$20
TARO PHARMACEUTICALS USA, INC.
$19
Helsinn Therapeutics (U.S.), Inc.
$19
Biofrontera Inc.
$18
DUSA Pharmaceuticals, Inc.
$17
Stemline Therapeutics Inc.
$15
Dermavant Sciences, Inc.
$15
Nabriva Therapeutics, plc
$12
Promius Pharma LLC
$12
MAYNE PHARMA COMMERCIAL LLC
$12
Merck Sharp & Dohme Corporation
$11
Mylan Pharmaceuticals Inc.
$11
Top 3 companies account for 37.0% of total payments
Associated products mentioned in payments ›
0.25% · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Aczone · Avar · BLU-U · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cabtreo · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · Cloderm Cream · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELZONRIS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Eletone · Erivedge · Exelderm · HALOG (Halcinonide Cream · HUMIRA · HYLATOPIC EMOLLIENT · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · Klisyri · LIBTAYO · Mupirocin Cream · ODOMZO · ODOMZO (sonidegib) capsules · ONEXTON · OPZELURA · ORACEA · Otezla · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Sivextro · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Tazorac · Tremfya · ULTRAVATE · USP) 0.1% · VALCHLOR · VTAMA · Winlevi · YCANTH · ZILXI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $620 per 100 Medicare services performed
Looking for a dermatology specialist in Prosper?
Compare dermatologists in the Prosper area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
113
Per 100K population
10.1
County median income
$117,588
Nearest hospital
COOK CHILDRENS MEDICAL CENTER PROSPER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lockhart is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lockhart experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Lockhart performed 916 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lockhart receive payments from pharmaceutical companies?
Yes. Dr. Lockhart received a total of $12,771 from 48 companies across 465 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lockhart's costs compare to other dermatologists in Prosper?
Dr. Lockhart's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lockhart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →